**Question:** False statement about Acyclovir is

A. Acyclovir is not effective against herpes simplex virus infection.
B. Acyclovir does not cross the blood-brain barrier.
C. Acyclovir causes severe hepatotoxicity in patients.
D. Acyclovir is ineffective against varicella-zoster virus infection.

**Correct Answer:** A. Acyclovir is not effective against herpes simplex virus infection.

**Core Concept:** Acyclovir is a nucleoside analogue antiviral drug, primarily used for treating viral infections caused by herpes simplex virus (HSV), varicella-zoster virus (VZV), and human papillomavirus (HPV).

**Why the Correct Answer is Right:** Acyclovir is a potent inhibitor of viral DNA polymerase, disrupting the viral replication process. It is highly effective against HSV and VZV infections but not against herpes simplex virus type 1 (HSV-1). HSV-1 primarily causes oral herpes and is primarily treated with other antiviral medications like acyclovir, famciclovir, and valacyclovir.

**Why Each Wrong Option is Incorrect:**

A. Acyclovir is effective against HSV-2 (genital herpes) and varicella-zoster virus (chickenpox and shingles). It is not specifically tailored for HSV-1 treatment.
B. Acyclovir does cross the blood-brain barrier and is effective against herpes encephalitis, which is caused by HSV.
C. Acyclovir is generally well-tolerated and safe, with minimal hepatotoxicity. The statement is incorrect and misleading.
D. Acyclovir is effective against HSV-1, but it is not as potent against HSV-2. Famciclovir is more suitable for HSV-2 treatment.

**Clinical Pearl:** Acyclovir is an essential drug for treating HSV and VZV infections, but it has limited efficacy against HSV-1. Famciclovir and valacyclovir are preferred for HSV-1 treatment due to their higher potency against this specific virus. Understanding the pharmacokinetic and pharmacodynamic differences among these antiviral medications is crucial for selecting the appropriate treatment for different herpes virus infections.